Identifying drugs with the greatest increases and decreases in spending per beneficiary using Medicare Part D: A cross-sectional study
Benazir Hodzic-Santor(Montreal Neurological Institute and Hospital), Michael Fralick(University Health Network), Chana A. Sacks(Harvard University), Tamara Van Bakel(Lunenfeld-Tanenbaum Research Institute)
Cited by 0
Related Papers
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
|New England Journal of Medicine|2020|1.4k
Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections
|Annals of Internal Medicine|2019|215
Paradigm Shifts in Heart-Failure Therapy — A Timeline
|New England Journal of Medicine|2014|114
Oral Anticoagulant Utilization in the United States and United Kingdom
|Journal of General Internal Medicine|2020|79
Biochemical observations following administration of taurine to patients with epilepsy
|Brain Research|1975|68